in this issue
People & Business :: Companies
Albemarle beats estimates despite sales decline
January 22, 2013 | Vincent Valk
Albemarle’s fourth-quarter net income totaled $37.7 million, or 42 cts/share down 17.1% from the year-ago period, on sales down 2.8% to $687.6 million. Excluding charges related to a change in pension accounting, as well as restructuring charges, adjusted net income totaled $105.2 million, or $1.17/share, beating analysts’ consensus of 99 cts/share, as reported by Thomson Reuters (New York). The decline in sales was driven by lower metals surcharges in the catalysts business, which offset volume growth, Albemarle says. Catalyst segment sales...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee